Fulgent Genetics (FLGT) Treasury Shares (2015 - 2026)

Fulgent Genetics has disclosed Treasury Shares across 12 years of filings, most recently posting $2.6 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.6 million, up 420.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (up 420.0% YoY), and the FY2025 annual result was $2.2 million, up 1.22% from the prior year.
• Treasury Shares came in at $2.6 million for Q1 2026 at Fulgent Genetics, up from $2.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.6 million in Q4 2022 to a low of $10000.0 in Q1 2024.
• The 5-year median for Treasury Shares is $600000.0 (2025), against an average of $1.1 million.
• Across the five-year window, Treasury Shares plunged 91.96% in 2023 and soared 5900.0% in 2025, its largest moves.
• Fulgent Genetics' Treasury Shares stood at $2.6 million in 2022, then decreased by 16.0% to $2.2 million in 2023, then fell by 0.18% to $2.2 million in 2024, then grew by 1.22% to $2.2 million in 2025, then rose by 16.44% to $2.6 million in 2026.
• The last three Treasury Shares figures came in at $2.6 million (Q1 2026), $2.2 million (Q4 2025), and $600000.0 (Q3 2025), per Business Quant data.